Alpha 2.0
Login Register
» Authors » Maganizo Chagomerana

Maganizo Chagomerana

Explore the profile of Maganizo Chagomerana including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 25
Citations 159
Followers 0
Related Specialties
Infectious Diseases
General Medicine
Public Health
Top 10 Co-Authors
Mina C Hosseinipour
Evaristar Kudowa
Victor Mwapasa
Jennifer H Tang
Tamiwe Tomoka
Emmanuel Singogo
Satish Gopal
Lameck Chinula
Esther Mathiya
Nora E Rosenberg
Published In
J Acquir Immune Defic Syndr
Sex Transm Dis
Transfus Med
J Int AIDS Soc
J Glob Health Econ Policy
Affiliations
Soon will be listed here.
Recent Articles
1.
Use of routinely collected blood donation data for expanded HIV and Syphilis surveillance in Blantyre district, Malawi
Singogo E, Hartney T, Bourdin S, Chagomerana M, Kudowa E, Puerto-Meredith S, et al.
PLoS One . 2024 Aug; 19(8):e0300647. PMID: 39186758
The World Health Organization recommends that all blood donations be screened for transfusion transmissible infections; these data are currently not incorporated into national disease surveillance efforts. We set out to...
2.
Characterizing HIV Acquisition Risk, Treatment Gaps, and Populations Reached Through Venue-Based Outreach and Clinical Services in Blantyre, Malawi: Findings From a District-wide CLOVE Study
Singogo E, Weir S, Kudowa E, Chagomerana M, Chapola J, Edwards J, et al.
J Acquir Immune Defic Syndr . 2024 Jul; 97(4):315-324. PMID: 39020465
Background: In 2017, Blantyre district had the highest adult HIV prevalence in Malawi (17.7%) and lowest viral suppression (60%). In response, the Ministry of Health expanded prevention and treatment services....
3.
HIV infection and ART exposure affect tumor TCR repertoire of diffuse large B cell lymphoma
Roush S, Coelho J, Xu A, Puranam K, Mponda M, Kasonkanji E, et al.
JCI Insight . 2024 May; 9(13). PMID: 38781015
The most common subtype of lymphoma globally, diffuse large B cell lymphoma (DLBCL), is a leading cause of cancer death in people with HIV. The restructuring of the T cell...
4.
Prevalence and incidence of transfusion-transmissible infections among blood donors in Malawi: A population-level study
Singogo E, Chagomerana M, Van Ryn C, Mbwana R, Likaka A, Mbaya B, et al.
Transfus Med . 2023 Oct; 33(6):483-496. PMID: 37828838
Background: Voluntary non-remunerated blood donors (VNRBDs) are essential to sustain national blood supplies. Expanding testing capacity for the major transfusion-transmitted infections (TTI) is crucial to ensure safe blood products. Understanding...
5.
Effectiveness of an intervention to increase uptake of voluntary medical male circumcision among men with sexually transmitted infections in Malawi: a preinterventional and postinterventional study
Matoga M, Kudowa E, Ndalama B, Bonongwe N, Mathiya E, Jere E, et al.
BMJ Open . 2023 Oct; 13(10):e072855. PMID: 37788927
Objective: To evaluate the effect a multistrategy demand-creation and linkage intervention on voluntary medical male circumcision (VMMC) uptake, time to VMMC and predictors of VMMC uptake among men with sexually...
6.
Costing and cost-effectiveness of Cepheid Xpert HIV -1 Qual Assay using whole blood protocol versus PCR by Abbott Systems in Malawi
Nyirenda-Nyangwa M, Manthalu G, Arnold M, Nkhoma D, Hosseinipour M, Chagomerana M, et al.
J Glob Health Econ Policy . 2023 Sep; 2. PMID: 37711180
Background: Timely diagnosis of HIV in infants and children is an urgent priority. In Malawi, 40,000 infants annually are HIV exposed. However, gold standard polymerase-chain-reaction (PCR) based testing requires centralised...
7.
Knowledge and perceptions about Dolutegravir and Dolutegravir counselling: a qualitative study among women living with HIV
Chapola J, Lee F, Bula A, Rosenberg N, Tseka J, Chagomerana M, et al.
BMC Womens Health . 2023 Sep; 23(1):478. PMID: 37689628
Introduction: In 2018, the Malawi Ministry of Health adopted the recommendation to switch first-line antiretroviral therapy (ART) from an efavirenz (EFV)-based to a dolutegravir (DTG)-based regimen. Little is known about...
8.
Systematic review of prevalence and risk factors of transfusion transmissible infections among blood donors, and blood safety improvements in Southern Africa
Puerto-Meredith S, Singogo E, Chagomerana M, Nthani T, Likaka A, Gondwe A, et al.
Transfus Med . 2023 Aug; 33(5):355-371. PMID: 37641525
Blood and blood products are listed as one of the essential medicines by the World Health Organization (WHO). In addition to inadequate supply, most sub-Saharan Africa (SSA) nations fail to...
9.
'If I am on ART, my new-born baby should be put on treatment immediately': Exploring the acceptability, and appropriateness of Cepheid Xpert HIV-1 Qual assay for early infant diagnosis of HIV in Malawi
Nyirenda-Nyangwa M, Kumwenda M, Horter S, Hosseinipour M, Chagomerana M, Kennedy N, et al.
PLOS Glob Public Health . 2023 Mar; 3(3):e0001135. PMID: 36962982
Early infant diagnosis of HIV (EID-HIV) is key to reducing paediatric HIV mortality. Traditional approaches for diagnosing HIV in exposed infants are usually unable to optimally contribute to EID. Point-of-care...
10.
Integrating Enhanced HIV Pre-exposure Prophylaxis Into a Sexually Transmitted Infection Clinic in Lilongwe: Protocol for a Prospective Cohort Study
Rutstein S, Matoga M, Chen J, Mathiya E, Ndalama B, Nyirenda N, et al.
JMIR Res Protoc . 2022 Dec; 11(12):e37395. PMID: 36469400
Background: Pre-exposure prophylaxis (PrEP) reduces HIV acquisition risk by >90% and is a critical lever to reduce HIV incidence. Identifying individuals most likely to benefit from PrEP and retaining them...